Hormone Therapy

In a recent study, 98% of transgender adolescents who were prescribed gender-affirming hormone treatment after using pubertal blockers continued to use gender-affirming hormones in adulthood.

PHILADELPHIA — Taking an “anatomy inventory” during visits can help cultivate a more supportive environment for transgender and non-binary patients to discuss their gender identity and the need for organ-specific care, a presenter here said.

The decision to ban gender-affirming care for youth in Florida will cause “irrevocable harm,” ACP President Ryan D. Mire, MD, MACP, said in a press release.

Most transgender adolescents who used pubertal blockers and were later prescribed gender-affirming hormone therapy in the Netherlands continued to use hormones as adults, according to data published in The Lancet Child & Adolescent Health.

SAN DIEGO — Multiple new anti-obesity medications currently in the pipeline could expand treatment options for the disease in the coming years, according to a speaker at ObesityWeek 2022.

The U.S. Preventive Services Task Force has released two final recommendations on the use of hormone therapy for the primary prevention of chronic conditions in postmenopausal people.

Adding localized radiation therapy to intermittent hormone therapy extended PFS among men with oligometastatic prostate cancer, data from the randomized phase 2 EXTEND trial showed.

A study of women with menopause aged 45 to 60 years found that menopausal hormone therapy may reduce the odds of developing adhesive capsulitis.

About 30% of a cohort of gender-diverse youths had low whole-body bone mineral density z scores prior to initiation of puberty blockers or gender-affirming hormones, according to findings published in Transgender Health.

Women who did not receive menopausal hormone therapy had greater odds of developing adhesive capsulitis compared with those on HT, according to preliminary study results presented at the North American Menopause Society annual meeting.